Printer Friendly
The Free Library
14,507,882 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Safety labeling changes approved by CDER--May 2007.


Desoxyn (methamphetamine hydrochloride meth·am·phet·a·mine hydrochloride
n.
A crystalline amine used as a central nervous system stimulant and in the treatment of obesity.
 tablets, USP USP - unique sales point )

BOXED WARNING

... Misuse of methamphetamine may cause sudden death and serious cardiovascular adverse events.
WARNINGS

The following five subsections have been added:

Serious Cardiovascular Events
  Sudden Death and Pre-existing Structural Cardiac
   Abnormalities or other Serious Heart Problems
      Children and Adolescents
      Adults
      Hypertension and other Cardiovascular Conditions
      Assessing Cardiovascular Status in Patients being
       Treated with Stimulant Medications
Psychiatric Adverse Events
  Pre-existing Psychosis
  Bipolar Illness
  Emergence of New Psychotic or Manic Symptoms
  Aggression
Long-Term Suppression of Growth
Seizures
Visual Disturbance

PRECAUTIONS

Information for Patients
  Medication Guide
Usage in Nursing Mothers
  Amphetamines are excreted in human milk.
  Mothers taking amphetamines should be advised to refrain from
   nursing.


MEDICATION GUIDE (new)

See highlighted prescribing information for new text..

Tindamax (tinidazole) Tablets for Oral Use

BOXED WARNING: Warning/Potential Risk for Carcinogenicity carcinogenicity /car·ci·no·ge·nic·i·ty/ (kahr?si-no-je-nis´i-te) the ability or tendency to produce cancer.

carcinogenicity

the ability or tendency to produce cancer.
 

Carcinogenicity has been seen in mice and rats treated chronically with metronidazole metronidazole /met·ro·ni·da·zole/ (-ni´dah-zol) an antiprotozoal and antibacterial effective against obligate anaerobes; used as the base or the hydrochloride salt. It is also used as a topical treatment for rosacea. , another nitroimidazole agent. Although such data have not been reported for tinidazole, the two drugs are structurally related and have similar biologic effects ...

CONTRAINDICATIONS

Potential Effects of Other Drugs on Tinidazole CYP CYP

In currencies, this is the abbreviation for the Cyprus Pound.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
3A4 Inducers and Inhibitors

The use of tinidazole is contraindicated:

In patients with a previous history of hypersensitivity hypersensitivity, heightened response in a body tissue to an antigen or foreign substance. The body normally responds to an antigen by producing specific antibodies against it. The antibodies impart immunity for any later exposure to that antigen.  to tinidazole or other nitroimidazole derivatives. Reported reactions have ranged in severity from urticaria urticaria /ur·ti·ca·ria/ (ur?ti-kar´e-ah) hives; a vascular reaction of the upper dermis marked by transient appearance of slightly elevated patches (wheals) which are redder or paler than the surrounding skin and often attended by  to Stevens Johnson syndrome ...

In nursing mothers: Interruption of breast-feeding breast-feeding /breast-feed·ing/ (brest´fed?ing) nursing; the feeding of an infant at the mother's breast.  is recommended during tinidazole therapy and for 3 days following the last dose ...

WARNINGS & PRECAUTIONS

Vaginal Candidiasis--The use of tinidazole may result in Candida vaginitis vaginitis

Inflammation of the vagina. The chief symptom is a whitish or yellowish vaginal discharge. Treatment depends on the cause: appropriate drugs for sexually transmitted diseases (often from Gardnerella bacteria or trichomonads) or yeast infections; estrogen cream for
. In a clinical study of 235 women who received tinidazole for bacterial vaginosis Bacterial Vaginosis Definition

Bacterial vaginosis (BV) is a type of vaginal infection in which the normal balance of bacteria in the vagina is disrupted, allowing the overgrowth of harmful anaerobic bacteria at the expense of protective bacteria.
, a vaginal fungal infection fungal infection, infection caused by a fungus (see Fungi), some affecting animals, others plants. Fungal Infections of Human and Animals
 developed in 11 (4.7%) of all study subjects ...

Drug Resistance--Prescribing Tindamax in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.
ADVERSE REACTIONS

Bacterial Vaginosis
Postmarketing Experience

USE IN SPECIFIC POPULATIONS

Pregnancy
  Teratogenic Effects: Pregnancy Category C
Pediatric Use
  Pediatric Administration
Renal Impairment
Hepatic Impairment


Truvada (emtricitabine and tenofovir disoproxil fumarate emtricitabine and tenofovir disoproxil fumarate

Truvada

Pharmacologic class: Nucleoside/nucleotide reverse-transcriptase inhibitor combination

Therapeutic class: Antiretroviral

Pregnancy risk category B
) Tablets

BOXED WARNING

... Truvada is not approved for the treament of chronic hepatitis Chronic hepatitis
Long lasting inflammation of the liver due to viruses or other causes.

Mentioned in: Tube Compression of the Esophagus and Stomach

chronic hepatitis 
 B virus (HBV HBV hepatitis B virus.

HBV
abbr.
hepatitis B virus
) infection and the safety and efficacy of Truvada have not been established in patients coinfected with HBV and HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. . Severe acute exacerbations of hepatitis B Hepatitis B Definition

Hepatitis B is a potentially serious form of liver inflammation due to infection by the hepatitis B virus (HBV). It occurs in both rapidly developing (acute) and long-lasting (chronic) forms, and is one of the most common chronic
 have been reported in patients who have discontinued Emtriva or Viread, the components of Truvada. Hepatic function hepatic function (h·paˑ·tik funkˑ·sh  should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who are coinfected with HIV and HBV and discontinue Truvada. If appropriate, initiation of anti-hepatitis B therapy may be warranted.

WARNINGS: Patients Coinfected with HIV and Hepatitis B Virus

See highlighted labeling for revised text.

WARNINGS: Renal Impairment

Emtricitabine and tenofovir are principally eliminated by the kidney. Renal impairment, including cases of acute renal failure acute renal failure Acute kidney failure Nephrology An abrupt decline in renal function, triggered by various processes–eg, sepsis, shock, trauma, kidney stones, drug toxicity-aspirin, lithium, substances of abuse, toxins, iodinated radiocontrast.  and Fanconi syndrome (renal tubular injury with severe hypophosphatemia), has been reported in association with the use of Viread.

It is recommended that creatinine clearance creatinine clearance
n.
The volume of serum or plasma that would be cleared of creatinine by one minute's excretion of urine.


creatinine clearance 
 be calculated in all patients prior to initiating therapy and as clinically appropriate during therapy with Truvada. Routine monitoring of calculated creatinine clearance and serum phosphorus should be performed in patients at risk for renal impairment ...

WARNINGS: Other

Truvada is a fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate. Truvada should not be coadministered with Atripla, Emitriva, or Viread. Due to similarities between emtricitabine and lamivudine, Truvada should not be coadministered with other drugs containing lamivudine, including Combivir (lamivudine/zidovudine), Epivir or Epivir-HBV (lamivudine), Epzicom (abacavir sulfate/lamivudine), or Trizivir (abacavir sulfate/lamivudine/zidovudine).
PRECAUTIONS

Drug Interactions
  Tenofovir Disoproxil Fumarate
Bone Effects
  Cases of osteomalacia ...
Information for Patients
  f
ADVERSE REACTIONS

Clinical Trials
  Study 934--Treatment Emergent Adverse Events
Postmarketing Experience
  Viread
    Skin and Subcutaneous Tissue Disorders
      Rash
    Musculoskeletal and Connective Tissue Disorders
      Myopathy
      Osteomalacia ...
    Renal and Urinary Disorders
      Interstitial Nephritis (including acute cases)
    General Disorders and Administration Site Conditions
      Asthenia


PATIENT PACKAGE INSERT package insert Pharmacology A synopsis of key physicochemical, pharmacologic, clinical efficacy, and clinical safety properties of a prescription drug, bundled therewith, intended to be highly readable and helpful to clinicians looking for specific  

What is the most important information I should know about Truvada?

Who should not take Truvada?

What should I tell my healthcare provider before taking Truvada?

What should I avoid while taking Truvada?

What are the possible side effects Side effects

Effects of a proposed project on other parts of the firm.
 of Truvada?

Viread (tenofovir disoproxil fumarate tenofovir disoproxil fumarate

Viread

Pharmacologic class: Nucleoside analog reverse transcriptase inhibitor

Therapeutic class: Antiretroviral

Pregnancy risk category B

) Tablets

BOXED WARNING

... Viread is not approved for the treatment of chronic hepatitis B virus (HBV) infection and the safety and efficacy of Viread have not been established in patients coinfected with HBV and HIV. Severe acute exacerbations of hepatitis B have been reported in patients who are coinfected with HBV and HIV and have discontinued Viread. Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who are coinfected with HIV and HBV and discontinue Viread. If appropriate, initiation of anti-hepatitis B therapy may be warranted.

WARNINGS: Patients Coinfected with HIV and Hepatitis B Virus

See highlighted prescribing information for revised text.

WARNINGS: Renal Impairment

Tenofovir is principally eliminated by the kidney. Renal impairment, including cases of acute renal failure and Fanconi syndrome (renal tubular injury with severe hypophosphatemia), has been reported in association with the use of Viread ...

It is recommended that creatinine clearance be calculated in all patients prior to initiating therapy and as clinically appropriate during therapy with Viread. Routine monitoring of calculated creatinine clearance and serum phosphorus should be performed in patients at risk for renal impairment ...

WARNINGS: Other

Viread should not be used in combination with the fixed-dose combination products Truvada or Atripla since it is a component of these products.
PRECAUTIONS

Drug Interactions
Bone Effects
  Cases of osteomalacia ...

ADVERSE REACTIONS

Postmarketing Experience
  Skin and Subcutaneous Tissue Disorders
    Rash
  Musculoskeletal and Connective Tissue Disorders
    Myopathy
    Osteomalcia ...
  Renal and Urinary Disorders
    Interstitial Nephritis (including acute cases)
  General Disorders and Administration Site Conditions
    Asthenia


PATIENT PACKAGE INSERT

Who should not take Viread?

What should I tell my healthcare provider before taking Viread?

What are the possible side effects of Viread?

Lovenox (enoxaparin sodium enoxaparin sodium Warning - High-alert drug!

Clexane (UK), Lovenox 3.

Pharmacologic class: Low-molecular-weight heparin

Therapeutic class: Anticoagulant

 injection) for Subcutaneous and Intravenous Use

CONTRAINDICATIONS

... Known hypersensitivity to enoxaparin sodium (e.g., pruritus pruritus /pru·ri·tus/ (proo-ri´tus) itching.prurit´ic

pruritus a´ni  intense chronic itching in the anal region.

pruritus hiema´lis  xerotic eczema.
, urticaria, anaphylactoid anaphylactoid /ana·phy·lac·toid/ (-fi-lak´toid) resembling anaphylaxis.

an·a·phy·lac·toid
adj.
Of or resembling anaphylaxis.
 reactions) ...

WARNINGS & PRECAUTIONS: Percutaneous Coronary Revascularization Procedures

To minimize the risk of bleeding following the vascular instrumentation during the treatment of unstable angina un·sta·ble angina
n.
Angina pectoris characterized by pain of coronary origin that occurs in response to less exercise or other stimuli than usually required to produce pain.
, non-Q-wave myocardial infarction myocardial infarction: see under infarction.  and acute ST-segment elevation myocardial infarction, adhere precisely to the intervals recommended between Lovenox doses. It is important to achieve hemostasis hemostasis /he·mo·sta·sis/ (he?mo-sta´sis) (he-mos´tah-sis)
1. the arrest of bleeding by the physiological properties of vasoconstriction and coagulation or by surgical means.

2.
 at the puncture site after PCI (1) (Payment Card Industry) See PCI DSS.

(2) (Peripheral Component Interconnect) The most widely used I/O bus (peripheral bus).
. In case a closure device is used, the sheath can be removed immediately. If a manual compression method is used, sheath should be removed 6 hours after the last IV/SC Lovenox. If the treatment with enoxaparin sodium is to be continued This article is about the Elton John box set. For the plot device commonly featuring the phrase "To be continued", see Cliffhanger.

To Be Continued
, the next scheduled dose should be given no sooner than 6 to 8 hours after sheath removal. The site of the procedure should be observed for signs of bleeding or hematoma hematoma /he·ma·to·ma/ (he?mah-to´mah) a localized collection of extravasated blood, usually clotted, in an organ, space, or tissue.  formation.
ADVERSE REACTIONS

Clinical Trials Experience
  Adverse Reactions in Lovenox-Treated Patients
   with Acute ST-Segment Elevation
   Myocardial Infarction

USE IN SPECIFIC POPULATIONS

Geriatric Use
  Prevention of DVT in hip, knee and abdominal
   surgery; treatment of DVT, Prevention of
   ischemic complications of unstable angina and
   non-Q-Wave myocardial infarction
    Lovenox should be used with care in
     geriatric patients who may show delayed
     elimination of enoxaprin.
  Treatment of acute ST-segment Elevation Myocardial
   Infarction (STEMI)
Hepatic Impairment


Norditropin Cartridges [somatropin (rDNA origin) injection] for Subcutaneous Use

CONTRAINDICATIONS: Acute Critical Illness

Treatment with pharmacologic amounts of somatropin is contraindicated in patients with acute critical illness ...

CONTRAINDICATIONS: Prader-Willi Syndrome Prader-Willi Syndrome Definition

Prader-Willi syndrome (PWS) is a genetic condition caused by the absence of chromosomal material from chromosome 15. The genetic basis of PWS is complex.
 in Children

Somatropin is contraindicated in patients with Prader-Willi syndrome who are severely obese, have a history of upper airway up·per airway
n.
The portion of the respiratory tract that extends from the nostrils or mouth through the larynx.
 obstruction or sleep apnea sleep apnea, episodes of interrupted breathing during sleep. Obstructive sleep apnea is a common disorder in which relaxation of muscles in the throat repeatedly close off the airway during sleep; the person wakes just enough to take a gasping breath. , or have severe respiratory impairment ...

CONTRAINDICATIONS: Hypersensitivity

... Localized reactions are the most common hypersensitivity reactions hypersensitivity reactions,
n.pl any of several forms of overly responsive actions of the immune system to normally encountered, antigens. Also called
allergic reactions.
 ...

WARNINGS & PRECAUTIONS: Acute Critical Illness

Increased mortality in patients with acute critical illness due to complications following open heart surgery, abdominal surgery or multiple accidental trauma, or those with acute respiratory failure Respiratory Failure Definition

Respiratory failure is nearly any condition that affects breathing function or the lungs themselves and can result in failure of the lungs to function properly.
 has been reported after treatment with pharmacologic amounts of somatropin ...

WARNINGS & PRECAUTIONS: Neoplasms

... Patients should be monitored carefully for potential malignant transformation malignant transformation Oncology The constellation of changes in the growth properties of cells in culture evoked by various agents–eg, radiation, toxins, and viruses that result in development of tumors  of skin lesions Skin Lesions Definition

A skin lesion is a superficial growth or patch of the skin that does not resemble the area surrounding it.
Description

Skin lesions can be grouped into two categories: primary and secondary.
, i.e. increased growth of preexisting pre·ex·ist or pre-ex·ist  
v. pre·ex·ist·ed, pre·ex·ist·ing, pre·ex·ists

v.tr.
To exist before (something); precede: Dinosaurs preexisted humans.

v.intr.
 nevi Nevus (plural, nevi)
The medical term for any anomaly of the skin that is present at birth, including moles and birthmarks.

Mentioned in: Malignant Melanoma, Moles


nevi

plural form of nevus.
.

WARNINGS & PRECAUTIONS: Fluid Retention

Fluid retention during somatropin replacement therapy in adults may frequently occur ...

WARNINGS & PRECAUTIONS: Progression of Preexisting Scoliosis Scoliosis Definition

Scoliosis is a side-to-side curvature of the spine.
Description

When viewed from the rear, the spine usually appears perfectly straight.
 in Pediatric Patients

... Skeletal abnormalities including scoliosis are commonly seen in untreated patients with Turner syndrome Turner syndrome

Chromosomal disorder (from the presence of only one sex chromosome, X, in all or some of the body's cells) that causes abnormal sexual development in females.
 and Noonan syndrome Noonan syndrome Turner-like syndrome Neonatology A group of specific abnormalities affecting both males and females, both sporadic in appearance but also reflecting a hereditary component, possibly AD Clinical Webbing of neck, pectus excavatum, facial  ...
ADVERSE REACTIONS

Clinical Trials Experience
  Clinical Trials in Children with Noonan Syndrome
Postmarketing Surveillance
  ... It is uncertain whether these cases of leukemia
   are related to GH therapy, the pathology of
   GHD itself, or other associated treatments such
   as radiation therapy ...
  The following additional adverse reactions ...
    Headaches (children & adults)
    Gynecomastia (children)
    Pancreatitis (children)


Rocephin (ceftriaxone sodium ceftriaxone sodium

Rocephin

Pharmacologic class: Third-generation cephalosporin

Therapeutic class: Anti-infective

Pregnancy risk category B

Action

) for Injection

See MedWatch Safety Alert posted 7/5/07 regarding Rocephin (ceftriaxone sodium) for Injection and recent labeling changes.

CONTRAINDICATIONS

Hyperbilirubinemic neonates, especially prematures, should not be treated with[] Rocephin. In vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment.

in vi·tro
adj.
In an artificial environment outside a living organism.
 studies have shown that ceftriaxone ceftriaxone /cef·tri·ax·one/ (cef?tri-ak´son) a semisynthetic, ß–resistant, third-generation cephalosporin effective against a wide range of gram-positive and gram-negative bacteria, used as the sodium salt.  can displace bilirubin Bilirubin

The predominant orange pigment of bile. It is the major metabolic breakdown product of heme, the prosthetic group of hemoglobin in red blood cells, and other chromoproteins such as myoglobin, cytochrome, and catalase.
 from its[] binding to serum albumin serum albumin
n.
See seralbumin.
 and bilimbin encephalopathy encephalopathy /en·ceph·a·lop·a·thy/ (en-sef?ah-lop´ah-the) any degenerative brain disease.

AIDS encephalopathy  HIV e.

anoxic encephalopathy  hypoxic e.
 can possibly develop in these patients.

Rocephin should not be administered concurrently with calcium-containing solutions or products in newborns because of the risk of precipitation of ceftriaxone-calcium salt (see WARNINGS).

WARNINGS

Ceftriaxone must not be mixed or administered simultaneously with calcium-containing solutions or products, even via different infusion lines.

Calcium-containing solutions or products must not be administered within 48 hours of last administration of ceftriaxone.

Cases of fatal reactions with calcium-ceftriaxone precipitates in lung and kidneys in both term and premature neonates have been described. In some cases the infusion lines and times of administration of ceftriaxone and calcium-containing solutions differed (see

CONTRAINDICATIONS and ADVERSE REACTIONS adverse reactions,
n.pl unfavorable reactions resulting from administration of a local anesthetic; responsible factors include the drug used, concentration, and route of administration.
).

ADVERSE REACTIONS

Cases of fatal reactions with calcium-ceftriaxone precipitates in lung and kidneys in both term and premature neonates have been described. In some cases the infusion lines and times of administration of ceftriaxone and calcium-containing solutions differed.

Aptivus (tipranvir) Capsules

WARNINGS: Effects on Platelet Aggregation Platelet aggregation
The clumping together of blood cells, possibly forming a clot.

Mentioned in: Herbalism, Traditional Chinese
 and Coagulation coagulation (kōăg'ylā`shən), the collecting into a mass of minute particles of a solid dispersed throughout a liquid (a sol), usually followed by the precipitation or  

Aptivus/ritonavir should be used with caution in patients who may be at risk of increased bleeding from trauma, surgery or other medical conditions, or who are receiving medications known to increase the risk of bleeding such as antiplatelet agents and anticoagulants Anticoagulants
Drugs that suppress, delay, or prevent blood clots. Anticoagulants are used to treat embolisms.

Mentioned in: Embolism, Heart Valve Replacement
, or who are taking supplemental high doses of vitamin E vitamin E
 or tocopherol

Fat-soluble organic compound found principally in certain plant oils and leaves of green vegetables. Vitamin E acts as an antioxidant in body tissues and may prolong life by slowing oxidative destruction of membranes.
. In in vitro experiments, tipranavir was observed to inhibit human platelet aggregation at levels consistent with exposures observed in patients receiving Aptivus/Ritonavir.

In rats, co-administration with vitamin E increased the bleeding effects of tipranavir (see ANIMAL PHARMACOLOGY AND TOXICOLOGY).

Avelox (moxifloxacin hydrochloride moxifloxacin hydrochloride

Avelox, Vigamox

Pharmacologic class: Fluoroquinolone

Therapeutic class: Anti-infective

Pregnancy risk category C

Action

) Tablets

Avelox I.V. (moxifloxacin hydrochloride in sodium chloride sodium chloride, NaCl, common salt. Properties


Sodium chloride is readily soluble in water and insoluble or only slightly soluble in most other liquids. It forms small, transparent, colorless to white cubic crystals.
 injection)

WARNINGS: Hypersensitivity Reactions

... Other serious and sometimes fatal events, some due to hypersensitivity, and some due to uncertain etiology, have been reported rarely in patients receiving therapy with quinolones, including Avelox. These events may be severe and generally occur following the administration of multiple doses. Clinical manifestations may include one or more of the following ...

The drug should be discontinued immediately at the first appearance of a skin rash, jaundice jaundice (jôn`dĭs, jän`–), abnormal condition in which the body fluids and tissues, particularly the skin and eyes, take on a yellowish color as a result of an excess of bilirubin. , or any other sign of hypersensitivity and supportive measures instituted ...

WARNINGS: Clostridium difficile Clostridium difficile A common cause of bacterial colitis; it is the causative agent in 99% of pseudomembranous colitis, and 20-30% of antibiotic-associated diarrhea  associated diarrhea (CDAD CDAD Clostridium Difficile-Associated Diarrhea
CDAD Component Data Administrator
)

Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including Avelox, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora Normal flora
The mixture of bacteria normally found at specific body sites.

Mentioned in: Sputum Culture, Wound Culture
 of the colon leading to overgrowth overgrowth

Rapid growth in the sales of a mutual fund's shares to the extent that the fund has difficulty finding promising new investments or it must take such large positions in individual investments that its trading flexibility is reduced.
 of C. difficile.

C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of C. difficile cause increased morbidity and mortality Morbidity and Mortality can refer to:
  • Morbidity & Mortality, a term used in medicine
  • Morbidity and Mortality Weekly Report, a medical publication
See also
  • Morbidity, a medical term
  • Mortality, a medical term
, as these infections can be refractory to antimicrobial therapy and may require colectomy colectomy /co·lec·to·my/ (ko-lek´tah-me) excision of the colon or of a portion of it.

co·lec·to·my
n.
Surgical removal of part or all of the colon.
. CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents. If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.
PRECAUTIONS

Information for Patients

   ... The risk of serious tendon disorders
   with quinolones is higher in those over
   65 years of age, especially those on corticosteroids.

   ... diarrhea is a common problem caused
   by antibiotics which usually ends when
   the antibiotic is discontinued. Sometimes
   after starting treatment with antibiotics,
   patients can develop watery and
   bloody stools (with or without stomach
   cramps and fever) even as late as two or
   more months after having taken the last
   dose of the antibiotic. If this occurs, patients
   should contact their physician as
   soon as possible.

Geriatric Use

   ... The clinical trial data demonstrate that
   the safety of intravenous moxifloxacin
   in patients aged 65 or older was similar
   to that of comparator-treated patients.

   ... In general, elderly patients may be
   more susceptible to drug-associated effects
   of the QT interval. Therefore,
   Avelox should be avoided in patients
   taking drugs that can result in prolongation
   of the QT interval (e.g. class IA or
   class III antiarrhythmics) or in patients
   with risk factors for torsade de pointes
   (e.g., known QT prolongation, uncorrected
   hypokalemia).

   ... Tendon rupture usually involves the
   Achilles, hand or shoulder tendons and
   can occur during therapy or up to a few
   months post completion of therapy ...

Postmarketing Adverse Event Reports

   Hepatic Failure, including fatal cases
   Toxic Epidermal Necrolysis

PATIENT PACKAGE INSERT

What are possible side effects of Avelox?

ChloraPrep (2% chlorhexidine gluconate
(w/v) topical solution) 3-mL applicator
with tint applicator containing FD&C
Green #3 dye

WARNINGS

Solution contains alcohol and gives off flammable vapors

Doxil (doxorubicin HCl liposome injection)

WARNINGS & PRECAUTIONS: Cardiac Toxicity
In the randomized multiple myeloma study, the incidence
of heart failure events (ventricular dysfunction,
cardiac failure, right ventricular failure, congestive cardiac
failure, chronic cardiac failure, acute pulmonary
edema and pulmonary edema) was similar in the Doxil +
bortezomib group and the bortezomib monotherapy
group, 3% in each group. LVEF decrease was defined as
an absolute decrease of [greater than or equal to] 15% over
baseline or a [greater than or equal to] 5%
decrease below the institutional lower limit of normal.
Based on this definition, 25 patients in the bortezomib
arm (8%) and 42 patients in the Doxil + bortezomib
arm (13%) experienced a reduction in LVEF.

ADVERSE REACTIONS

Overall Adverse Reactions Profile
  Cardiac Toxicity
  Infusion Reactions
  Myelosuppression
  Hand-Foot Syndrome
Adverse Reactions in Clinical Trials
  Initial Paragraph
  Patients With Multiple Myeloma
    Table 10
  Postmarketing Experience
Use in Specific Populations
  Geriatric Use


Factive Fac´tive

a. 1. Making; having power to make.
 (gemifloxacin mesylate gemifloxacin mesylate

Factive

Pharmacologic class: Quinolone

Therapeutic class: Broad-spectrum anti-infective

Pregnancy risk category C

Action

) Tablets WARNINGS

WARNINGS: QT Effects

... No cardiovascular morbidity or mortality attributable to QTc prolongation occurred with Factive treatment in over 8119 patients, including 707 patients concurrently receiving drugs known to prolong the QTc interval and 7 patients with hypokalemia Hypokalemia Definition

Hypokalemia is a condition of below normal levels of potassium in the blood serum. Potassium, a necessary electrolyte, facilitates nerve impulse conduction and the contraction of skeletal and smooth muscles, including the heart.
 ...

WARNINGS: Hypersensitivity Reactions Serious hypersensitivity and/or anaphylactic anaphylactic /ana·phy·lac·tic/ (an?ah-fi-lak´tik) pertaining to anaphylaxis.
anaphylactic (an´
 reactions have been reported in patients receiving fluoroquinolone fluoroquinolone /flu·o·ro·quin·o·lone/ (-kwin´o-lon) any of a subgroup of fluorine-substituted quinolones, having a broader spectrum of activity than nalidixic acid.

fluor·o·quin·o·lone
n.
 therapy, including Factive. Hypersensitivity reactions reported in patients receiving fluroquinolone therapy have occasionally been fatal ...

... Clinical manifestations may include one or more of the following, fever [added to list]

... The drug should be discontinued immediately at the first appearance of a skin rash, jaundice, or any other sign of hypersensitivity and supportive measures instituted ...

WARNINGS: Clostridium difficile associated Diarrhea (CDAD)

Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including Factive, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile. C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. MAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since MAD has been reported to occur over two months after the administration of antibacterial agents.

If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.
PRECAUTIONS

Rash
   Table 2
Information for Patients
   ... Rash occurs more commonly in those under
   40, especially women and in women on
   hormone replacement therapy. The incidence
   of rash increases with duration more than 5
   days and particularly longer than 7 days.

   ... diarrhea is a common problem caused by
   antibiotics which usually ends when the antibiotic
   is discontinued. Sometimes after starting
   treatment with antibiotics, patients can
   develop watery and bloody stools (with or
   without stomach cramps and fever) even as
   late as two or more months after having
   taken the last dose of the antibiotic. If this
   occurs, patients should contact their physician
   as soon as possible

   ... other central nervous system problems such
   as tremors, restlessness, lightheadedness, confusion
   and hallucinations may occur rarely
Geriatric Use

ADVERSE REACTIONS

Initial Section
Adverse Events with a Frequency of Less than 1%
Table 3
Laboratory Changes
Postmarketing Adverse Reactions


PATIENT PACKAGE INSERT

What are possible side effects of Factive?

What are the ingredients in Factive?

Floxin Tablets (ofloxacin tablets)

WARNINGS: Clostridium difficile associated diarrhea (CDAD)

Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including Floxin, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile. C. difficile produces toxins A and B which contribute to the development of CDAD. Hyper toxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.

If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.

PRECAUTIONS

Information for Patients
   ... diarrhea is a common problem caused by
   antibiotics which usually ends when the antibiotic
   is discontinued. Sometimes after starting
   treatment with antibiotics, patients can
   develop watery and bloody stools (with or
   without stomach cramps and fever) even as
   late as two or more months after having
   taken the last dose of the antibiotic. If this
   occurs, patients should contact their physician
   as soon as possible.


Fragmin (dalteparin sodium injection) for Subcutaneous Use Only

WARNINGS: Thrombocytopenia Thrombocytopenia Definition

Thrombocytopenia is an abnormal drop in the number of blood cells involved in forming blood clots. These cells are called platelets.
 

In Fragmin clinical trials supporting non-cancer indications, platelet counts of < 100,000/[mm.sup.3] and < 50,000/[mm.sup.3] occurred in < 1% and < 1% of patients, respectively.

In the clinical trial of patients with cancer and acute symptomatic venous thromboembolism thromboembolism /throm·bo·em·bo·lism/ (-em´bo-lizm) obstruction of a blood vessel with thrombotic material carried by the blood from the site of origin to plug another vessel.

throm·bo·em·bo·lism
n.
 treated for up to 6 months in the Fragmin treatment arm, platelet counts of < 100,000/[mm.sup.3] occurred in 13.6% of patients, including 6.5% who also had platelet counts less than 50,000/[mm.sup.3]. In the same clinical trial, thrombocytopenia was reported as an adverse event in 10.9% of patients in the Fragmin arm and 8.1% of patients in the OAC OAC On Approved Credit
OAC Online Archive of California (California Digital Library)
OAC Ohio Athletic Conference
OAC Ontario Arts Council (Canada)
OAC Ontario Agricultural College
 arm ...
PRECAUTIONS
  Drug/Laboratory Test Interactions
    Elevations of Serum Transaminases
ADVERSE REACTIONS
  Postmarketing Experience


Geodon (ziprasidone HCl) Capsules Geodon (ziprasidone mesylate) for Injection for IM Use Only

WARNINGS: QT Prolongation and Risk of Sudden Death

... Although torsade de pointes tor·sade de pointes
n.
Paroxysms of ventricular tachycardia in which the electrocardiogram shows a steady undulation in the QRS axis in runs of 5 to 20 beats and with progressive changes in direction.
 has not been observed in association with the use of ziprasidone at recommended doses in premarketing studies and experience is too limited to rule out an increased risk, there have been rare post-marketing reports (in the presence of multiple confounding factors) ...
ADVERSE REACTIONS

Other Events Observed During Postmarketing Use
  Reproductive System and Breast Disorders
    Priapism
  Nervous System Disorders
    Mania/Hypomania
    Serotonin Syndrome (alone or in combination with serotonergic
     medicinal products)
    Syncope
  Skin and Subcutaneous Tissue Disorders
    Allergic Reaction (such as allergic dermatitis, angioedema,
     orofacial edema, urticaria)


Haldol Decanoate (haloperidol haloperidol /hal·o·peri·dol/ (hal?o-per´i-dol) an antipsychotic agent of the butyrophenone group with antiemetic, hypotensive, and hypothermic actions; used especially in the management of psychoses and to control vocal utterances and ) for IM Injection Only

WARNINGS: Cardiovascular Effects

Cases of sudden death have been reported in psychiatric patients receiving antipsychotic drugs, including Haldol Decanoate.

Since QT-prolongation has been observed during Haldol Decanoate treatment, it is advised to be cautious in patients with QT-prolonging conditions (long QT-syndromes, hypokalaemia, electrolyte imbalance, drugs known to prolong QT, cardiovascular diseases, family history of QT prolongation). HALDOL DECANOATE MUST NOT BE ADMINISTERED INTRAVENOUSLY.
ADVERSE REATIONS

Cardiovascular Effects
  Tachycardia, hypotension, and hypertension
  have been reported. QT prolongation and/or
  ventricular arrhythmias have also been reported,
  in addition to ECG pattern changes
  compatible with the polymorphous configuration
  of torsade de pointes, and may occur
  more frequently with high doses and in predisposed
  patients ...

Cases of sudden and unexpected death have
been reported in association with the administration
of Haldol ...


Haldol (haloperidol) Injection for Immediate Release

WARNINGS: Cardiovascular Effects

Cases of sudden death have been reported in psychiatric patients receiving antipsychotic drugs, including Haldol. Since QT-prolongation has been observed during Haldol treatment, it is advised to be cautious in patients with QT-prolonging conditions (long QT-syndromes, hypokalaemia, electrolyte imbalance, drugs known to prolong QT, cardiovascular diseases, family history of QT prolongation). HALDOL INJECTION IS NOT APPROVED FOR INTRAVENOUS ADMINISTRATION.

ADVERSE REATIONS

Cardiovascular Effects
   Tachycardia, hypotension, and hypertension
   have been reported. QT prolongation and/or
   ventricular arrhythmias have also been reported,
   in addition to ECG pattern changes
   compatible with the polymorphous configuration
   of torsade de pointes, and may occur
   more frequently with high doses and in predisposed
   patients ...

   Cases of sudden and unexpected death have
   been reported in association with the administration
   of Haldol ...


Levaquin (levofloxacin) Tablets and Oral Solution

Levaquin (levofloxacin) Injection

Levaquin (levofloxacin in 5% dextrose dextrose: see glucose. ) Injection

WARNINGS

WARNINGS: Clostridium difficile associated diarrhea (CDAD)

Clostridium difficile ssociated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including Levaquin, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile. C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents. If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.

PRECAUTIONS

Information for Patients
   ... diarrhea is a common problem caused by
   antibiotics which usually ends when the antibiotic
   is discontinued. Sometimes after starting
   treatment with antibiotics, patients can develop
   watery and bloody stools (with or without stomach
   cramps and fever) even as late as two or
   more months after having taken the last dose of
   the antibiotic. If this occurs, patients should
   contact their physician as soon as possible.


ADVERSE REACTIONS

Postmarketing Adverse Reactions

PATIENT PACKAGE INSERT

What are the possible side effects of Levaquin?

NegGram Caplets (nalidixic acid, USP) WARNINGS: Clostridium difficile associated diarrhea (CDAD)

Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including NegGram, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents. If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.

PRECAUTIONS

Information for Patients
   ... diarrhea is a common problem caused by
   antibiotics which usually ends when the antibiotic
   is discontinued. Sometimes after starting
   treatment with antibiotics, patients can
   develop watery and bloody stools (with or
   without stomach cramps and fever) even as
   late as two or more months after having
   taken the last dose of the antibiotic. If this
   occurs, patients should contact their physician
   as soon as possible.


Norvir (ritonavir ritonavir /ri·to·na·vir/ (ri-to´nah-vir) an HIV protease inhibitor used in treatment of HIV infection and AIDS.

ri·ton·a·vir
n.
 capsules) Soft Gelatin gelatin or animal jelly, foodstuff obtained from connective tissue (found in hoofs, bones, tendons, ligaments, and cartilage) of vertebrate animals by the action of boiling water or dilute acid.  (ritonavir oral solution)

WARNINGS: Drug Interactions

Tipranavir co-administered with 200 mg of ritonavir has been associated with reports of clinical hepatitis and hepatic decompensation decompensation /de·com·pen·sa·tion/ (de?kom-pen-sa´shun)
1. inability of the heart to maintain adequate circulation, marked by dyspnea, venous engorgement, and edema.

2.
 including some fatalities. Extra vigilance is warranted in patients with chronic hepatitis B or hepatitis C co-infection, as these patients have an increased risk of hepatotoxicity hepatotoxicity (hepˑ··tō·t .
PRECAUTIONS
   Drug Interactions
      Table 6
          HIV Protease Inhibitor
          Atazanavir
          Daunavir
          Fosamprenavir
          Saquinavir
          Tipranavir


PegIntron (peginterferon alfa-2b) Powder for Injection

WARNINGS: Neuropsychiatric neu·ro·psy·chi·a·try  
n.
The medical study of disorders with both neurological and psychiatric features.



neu
 Events

Life-threatening or fatal neuropsychiatric events, including suicide, suicidal and homicidal hom·i·cid·al  
adj.
1. Of or relating to homicide.

2. Capable of or conducive to homicide: a homicidal rage.
 ideation ideation /ide·a·tion/ (i?de-a´shun) the formation of ideas or images.idea´tional

i·de·a·tion
n.
The formation of ideas or mental images.
, depression, relapse of drug addiction/overdose, and aggressive behavior sometimes directed towards others have occurred in patients with and without a previous psychiatric disorder during PegIntron treatment and follow-up ...

ADVERSE REACTIONS

Postmarketing Experience Pure Red Cell Aplasia pure red cell aplasia Hematology A type of anemia caused by selective depletion of erythroid cells

Pure red cell aplasia types

Acute
 

MEDICATION GUIDE

What is the most important information I should know about PegIntron and PegIntron/Rebetol combination therapy?

Plavix (clopidogrel bisulfate tablets) WARNINGS: Thrombotic Thrombocytopenic Purpura thrombotic thrombocytopenic purpura
n.
A disease of unknown origin, characterized by abnormally low levels of platelets in the blood, the formation of blood clots in the arterioles and capillaries of many organs, and neurological damage.
 (TTP TTP (thymidine triphosphate): see thymine. )

TTP has been reported rarely following use of Plavix, sometimes after a short exposure (<2 weeks). TTP is a serious condition that can be fatal and requires urgent treatment including plasmapheresis plasmapheresis, see apheresis.  (plasma exchange). It is characterized by thrombocytopenia, microangiopathic hemolytic anemia mic·ro·an·gi·o·path·ic hemolytic anemia
n.
The fragmentation of red blood cells because of narrowing or obstruction of small blood vessels.
 (schistocytes [fragmented RBCs] seen on peripheral smear), neurological findings, renal dysfunction, and fever.

PRECAUTIONS

Information for Patients
   Patients should be told that it may take them
   longer than usual to stop bleeding, that they
   may bruise and/or bleed more easily when
   they take Plavix or Plavix combined with aspirin,
   and that they should report any unusual
   bleeding to their physician. Patients should
   inform physicians and dentists that they are
   taking Plavix and/or any other product
   known to affect bleeding before any surgery
   is scheduled and before any new drug is
   taken.


Rapamune (sirolimus) Oral Solution and Tablets

WARNINGS

Hypersensitivity reactions, including anaphylactic/anaphylactoid reactions, angioedema, exfoliative dermatitis, and hypersensitivity vasculitis, have been associated with the administration of sirolimus ...

Exfoliative Dermatitis (term added)
PRECAUTIONS

Renal Function

   ... In patients with delayed graft function, Rapamune
   may delay recovery of renal function.

Proteinuria

   ... The safety and efficacy of conversion from
   calcineurin inhibitors to Rapamune in maintenance
   renal transplant population has not
   been established.

ADVERSE REACTIONS

Other Clinical Experience

   Exfoliative Dermatitis
   Nephrotic Syndrome
   ... In patients with delayed graft function, Rapamune
   may delay recovery of renal function.


WARNINGS

WARNINGS: Clostridium difficile associated diarrhea (CDAD)

Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including Tygacil, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile. C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents. If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.

PRECAUTIONS

Information for Patients
   ... Diarrhea is a common problem caused by
   antibiotics which usually ends when the antibiotic
   is discontinued. Sometimes after starting
   treatment with antibiotics, patients can
   develop watery and bloody stools (with or
   without stomach cramps and fever) even as
   late as two or more months after having
   taken the last dose of the antibiotic. If this
   occurs, patients should contact their physician
   as soon as possible.


Adderall XR (mixed salts of a single entity amphetamine amphetamine (ămfĕt`əmēn), any one of a group of drugs that are powerful central nervous system stimulants. Amphetamines have stimulating effects opposite to the effects of depressants such as alcohol, narcotics, and barbiturates.  product) Extended-Release Capsules
PRECAUTIONS

Information for Patients
  Medication Guide


MEDICATION GUIDE (new)

Anzemet Injection (dolasetron mesylate injection)
PRECAUTIONS

Pediatric Use

   Dolasetron should be administered with caution
   in pediatric patients who have or may develop
   prolongation of cardiac conduction intervals,
   particularly QTc. Rare cases of sustained supraventricular
   and ventricular arrhythmias, cardiac
   arrest leading to death, and myocardial infarction
   have been reported in children and adolescents ...

Anzemet Tablets (dolasetron mesylate)

PRECAUTIONS

Pediatric Use

   Dolasetron should be administered with caution
   in pediatric patients who have or may develop
   prolongation of cardiac conduction intervals,
   particularly QTc. Rare cases of sustained supraventricular
   and ventricular arrhythmias, cardiac
   arrest leading to death, and myocardial infarction
   have been reported in children and adolescents ...


BenzaClin Topical Gel (clindamycin--benzoyl peroxide gel)

PRECAUTIONS

Carcinogenesis car·ci·no·gen·e·sis
n.
The production of cancer.



carcinogenesis

production of cancer.


biological carcinogenesis
viruses and some parasites are capable of initiating neoplasia.
, Mutagenesis mutagenesis /mu·ta·gen·e·sis/ (mu?tah-jen´e-sis)
1. the production of change.

2. the induction of genetic mutation.


mu·ta·gen·e·sis
n. pl.
, Impairment of Fertility
   In a 2-year dermal carcinogenicity study in rats,
   treatment with BenzaClin Topical Gel at doses
   of 100, 500, and 2000 mg/kg/day caused a
   dose-dependent increase in the incidence of
   keratoacanthoma at the treated skin site of male
   rats. The incidence of keratoacanthoma at the
   treated site of males treated with 2000
   mg/kg/day (8 times the highest recommended
   adult human dose of 2.5 g BenzaClin Topical
   Gel, based on mg/m2) was statistically significantly
   higher than that in the sham- and vehicle-controls.


Concerta (methylphenidate HCl) Extended-Release Tablets
PRECAUTIONS
  Information for Patients
    Medication Guide
MEDICATION GUIDE (new)

Daytrana (methylphenidate transdermal
system)

PRECAUTIONS
  Information for Patients
    Medication Guide
MEDICATION GUIDE (new)

Dexedrine (dextroamphetamine sulfate)
Spansule Sustained-Release Capsules
and Tablets

PRECAUTIONS
  Information for Patients
    Medication Guide
MEDICATION GUIDE (new)

Metadate CD (methylphenidate HCl,
USP) Extended-Release Capsules

PRECAUTIONS
  Information for Patients
    Medication Guide
MEDICATION GUIDE (new)

MS Contin (morphine sulfate controlled-release)
Tablets

PRECAUTIONS
  General
    Initial Sentence
    Morphine may aggravate convulsions in patients
     with convulsive disorders, and all
     opioids may induce or aggravate seizures in
     some clinical settings
  Use in Pancreatic/Biliary Tract Disorders Tolerance
  Physical Dependence
  Pregnancy: Teratogenic Effects: Category C
    MS Contin should be used in pregnant
     women only if the need for strong opioid an
     algesia clearly outweighs the potential risk to
     the fetus ...
  Neonatal Withdrawal Syndrome
ADVERSE REACTIONS
  Less Frequently Observed Reactions
    Gastrointestinal
      Dyspepsia
    Genitourinary
      Amenorrhea
    Other
      Bronchospasm


Ortho Tri-Cyclen Tablets Ortho-Cyclen Tablets (norgestimate/ethinyl estradiol)

PRECAUTIONS

Pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children.

pe·di·at·ric
adj.
Of or relating to pediatrics.
 Use
   ... There was no significant difference between
   Ortho Tri-Cyclen Tablets and placebo in mean
   change in total lumbar spine (L1-L4) and total
   hip bone mineral density between baseline and
   Cycle 13 in 123 adolescent females with anorexia
   nervosa in a double-blind, placebo-controlled,
   multicenter, one-year treatment duration
   clinical trial for the Intent To Treat (ITT)
   population ...


Prevpac (lansoprazole 30-mg capsules, amoxicillin amoxicillin /amox·i·cil·lin/ (ah-mok?si-sil´in) a semisynthetic derivative of ampicillin effective against a broad spectrum of gram-positive and gram-negative bacteria.

a·mox·i·cil·lin
n.
 500-mg capsules, USP, and clarithromycin 500-mg tablets, USP)

PRECAUTIONS

Drug Interactions

Prevacid
   ... Prevacid substantially decreases the
   systemic concentrations of the HIV
   protease inhibitor atazanavir, which is
   dependent upon the presence of gastric
   acid for absorption, and may result in a
   loss of therapeutic effect of atazanavir
   and the development of HIV resistance ...

   ... It is theoretically possible that Prevacid
   may also interfere with the absorption
   of other drugs where gastric
   pH is an important determinant of
   bioavailability (e.g., ketoconazole, ampicillin
   esters, iron salts, digoxin).

ADVERSE REACTIONS

  Postmarketing
    Musculoskeletal System
      Myositis
    Urogenital System
      Interstitial Nephritis


Primacor (milrinone lactate injection) Primacor Flexible Containers (200 mcg/mL in 5% Dextrose Injection)
PRECAUTIONS

General

   There is no experience in controlled trials
   with infusions of milrinone for periods exceeding
   48 hours. Cases of infusion site reaction
   have been reported with intravenous milrinone
   therapy. Consequently, careful monitoring
   of the infusion site should be maintained
   to avoid possible extravasation.

ADVERSE REACTIONS

  Postmarketing Adverse Event Reports
    Isolated spontaneous reports of Bronchospasm and Anaphylactic Shock
    Liver Function Test Abnormalities
    Skin Reactions such as Rash
    Administration Site Conditions
      Infusion Site Reaction


Verelan PM (verapamil hydrochloride) Extended-Release Capsules Controlled Onset

PRECAUTIONS

Drug-Drug Interactions
   Hypotension, bradyarrhythmias, and
   lactic acidosis have been observed in
   patients receiving concurrent telithromycin,
   an antibiotic in the ketolide class
   of antibiotics.


Dyazide (hydrochlorothiazide/triamterene) Capsules
ADVERSE REACTIONS
  Hypersensitivity
    Subacute Cutaneous Lupus Erythematosus-like Reactions
  Metabolic
    Hypokalemia
    Hyponatremia
    Acidosis
    Hypercalcemia


Intron Intron

In split genes, a portion that is included in ribonucleic acid (RNA) transcripts but is removed from within a transcript during RNA processing and is rapidly degraded.
 A (interferon alfa-2b, recombinant) for Injection

ADVERSE REACTIONS

Postmarketing Experience

Prevacid I.V. (lansoprazole) for Injection
ADVERSE REACTIONS
  Postmarketing
    Musculoskeletal System
      Myositis
    Urogenital System
      Interstitial Nephritis


Levemir FlexPen (insulin detemir [rDNA origin] injection) in a 3 mL Pre-filled Syringe

PATIENT PACKAGE INSERT

What is Levemir?

Levemir (insulin detemir [rDNA origin] injection) 3 mL PenFill Disposable Cartridge

PATIENT PACKAGE INSERT

What is Levemir?

Naprelan (naproxen sodium) Controlled Release Tablets
NSAID MEDICATION GUIDE

Table: NSAID medicines that need a prescription

Vicoprofen

   Vicoprofen contains the same dose of
   ibuprofen as over-the-counter (OTC)
   NSAID, and is usually used for less
   than 10 days to treat pain. The OTC
   NSAID label warns that long term continuous
   use may increase the risk of
   heart attack or stroke. (included as
   footer)
COPYRIGHT 2007 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Adverse Event Reporting News
Geographic Code:1USA
Date:Aug 27, 2007
Words:5457
Previous Article:Gobburu named Director of Pharmacometrics.(FDA management)(Brief article)
Next Article:FDA amendments give agency broad powers over drug safety, ad fines.(FDA reform)(Food and Drug Administration)
Topics:



Related Articles
FDA directs ADHD drug manufacturers to notify patients about adverse events.(Drug Safety)(Attention Deficit Hyperactivity Disorder)
FDA issues guidance on drug safety communication.(Drug Safety)
FDA piloting safety studies of NMEs, revamping AERS, based on IOM recommendations.(Post-marketing surveillance)(new molecular entities)(Adverse Event...
Safety labeling changes approved by CDER--April 2007.(Center for Drug Evaluation and Research)
FDA crackdown on unapproved 'legacy drugs' draws fire.(FDA management)
FDA releases draft 5-year drug safety plan.(User fees/pharmacovigilance)(Food and Drug Administration Amendments Act )
FDA devises initial list of drugs and biologics for REMS.(Drug safety/REMS)(Food and Drug Administration Amendments Act of 2007 )
Legislation could be most significant change in drug law since 1962: CDER's Throckmorton.(FDAAA 2007)
Top Dem committee chairs blast latest FDA proposal.(Warning labels)
Legislation marks significant boost to FDA post-market safety efforts.(Drug safety/pharmacovigilance)(Food and Drug Administration)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles